Novo Nordisk Rolls out Ozempic in India at ₹2,200 per Week Amid Patent Disputes
Novo Nordisk, the Denmark-based pharmaceutical major, has formally introduced its widely used diabetes and weight-management drug Ozempic in the Indian…
Reuters
Read More